Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
mRNA-4359 advances to phase 2 following encouraging results in checkpoint inhibitor-resistant Melanoma
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
Merck will showcase results in innovative solutions in HIV treatment and prevention
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Subscribe To Our Newsletter & Stay Updated
